Obesity Research & Clinical Practice
Volume 6, Issue 1 , Pages e9-e20, January 2012

Dysmetabolic signals in “metabolically healthy” obesity

  • Peter Manu

      Affiliations

    • Hofstra North Shore LIJ School of Medicine, Hempstead, NY, United States
    • Zucker Hillside Hospital, Glen Oaks, NY, United States
    • Corresponding Author InformationCorresponding author at: Medical Services, Zucker Hillside Hospital, 59-75 263rd Street, Glen Oaks, NY 11004, United States. Tel.: +1 718 470 8290.
  • ,
  • Constantin Ionescu-Tirgoviste

      Affiliations

    • University of Medicine and Pharmacy “C. Davila”, Bucharest, Romania
  • ,
  • James Tsang

      Affiliations

    • Feinstein Institute for Medical Research, Manhasset, NY, United States
  • ,
  • Barbara A. Napolitano

      Affiliations

    • Feinstein Institute for Medical Research, Manhasset, NY, United States
  • ,
  • Martin L. Lesser

      Affiliations

    • Feinstein Institute for Medical Research, Manhasset, NY, United States
  • ,
  • Christoph U. Correll

      Affiliations

    • Hofstra North Shore LIJ School of Medicine, Hempstead, NY, United States
    • Zucker Hillside Hospital, Glen Oaks, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States

Received 6 March 2011; received in revised form 6 April 2011; accepted 11 April 2011. published online 25 May 2011.

Summary 

Background

Obesity is associated with decreased insulin sensitivity, atherogenic dyslipidemia and hypertension, but clinical studies have also identified a “metabolically healthy” obese phenotype.

Objective

To compare the characteristics of so-called “metabolically healthy” obese (MHO), normal weight subjects (MHNW) and obese with insulin resistance in the United States National Health and Nutrition Examination Survey, 1999-2004 (NHANES).

Design, setting and participants

Insulin resistance was defined by a homeostatic model assessment (HOMA) value in the upper tertile for the entire NHANES cohort. “Metabolic health” was defined as the absence of diabetes, insulin resistance, metabolic syndrome, and lipid-lowering therapy. The study evaluated the 314 MHO, 1173 MHNW and 843 insulin-resistant obese from among the 6485 non-diabetic, non-pregnant adults aged 20–79 years.

Main outcome measures

Demographic, metabolic, nutrition and physical activity features.

Results

MHO and MHNW groups were similar regarding age, and fasting glucose and triglyceride levels. MHO had higher insulin (P<0.0001), insulin resistance as measured with the homeostatic model (P<0.0001), non-HDL cholesterol (P=0.002 in females and P=0.049 in males) and C-reactive protein levels (P<0.0001 in females and P=0.038 in males), and lower high-density lipoprotein cholesterol (HDL) levels (P<0.002). In addition, MHO females had higher low-density lipoprotein (LDL) cholesterol levels (P=0.012) and systolic blood pressure (P=0.02), and lower intake of dietary fiber (P=0.0009) and levels of physical activity (P=0.002). Triglycerides levels were normal in the MHO group.

Conclusions

“Metabolically healthy” obese people have multiple dysmetabolic changes that may signal increased risk for coronary artery disease.

Keywords: Obesity, Metabolic Health, HDL-cholesterol, Non-HDL-choleserol, Coronary risk

 

PII: S1871-403X(11)00023-8

doi:10.1016/j.orcp.2011.04.003

Obesity Research & Clinical Practice
Volume 6, Issue 1 , Pages e9-e20, January 2012